Marsh & McLennan Companies, Inc. (NYSE:MRSH – Get Free Report) Director Lloyd Yates sold 12,000 shares of the firm’s stock in a transaction on Thursday, July 23rd. The stock was sold at an average price of $175.65, for a total value of $2,107,800.00. Following the completion of the sale, the director directly owned 12,001 shares of the company’s stock, valued at approximately $2,107,975.65. This trade represents a 50.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Marsh & McLennan Companies Price Performance
Shares of MRSH opened at $191.50 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The firm has a market cap of $91.38 billion, a P/E ratio of 23.41, a price-to-earnings-growth ratio of 2.83 and a beta of 0.61. The firm has a 50-day simple moving average of $172.84. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $213.80.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.89 by $0.07. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The firm had revenue of $7.28 billion for the quarter. The firm’s revenue was up 6.2% compared to the same quarter last year. Equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.43 earnings per share for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
Analysts Set New Price Targets
A number of research firms have issued reports on MRSH. Keefe, Bruyette & Woods lifted their target price on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research note on Friday, April 17th. Citigroup downgraded shares of Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price target on the stock. in a report on Wednesday, July 22nd. Wells Fargo & Company upped their price objective on shares of Marsh & McLennan Companies from $186.00 to $188.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 22nd. Weiss Ratings lowered Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Finally, UBS Group boosted their price target on Marsh & McLennan Companies from $212.00 to $216.00 and gave the stock a “buy” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $201.94.
Get Our Latest Stock Report on Marsh & McLennan Companies
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of MRSH. Solstein Capital LLC acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter worth about $25,000. Asset Dedication LLC acquired a new stake in Marsh & McLennan Companies in the 1st quarter valued at approximately $25,000. SHP Wealth Management bought a new position in Marsh & McLennan Companies in the 4th quarter worth approximately $26,000. KERR FINANCIAL PLANNING Corp bought a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at approximately $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter worth $27,000. Institutional investors and hedge funds own 87.99% of the company’s stock.
About Marsh & McLennan Companies
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
